The adjusted relationship between demographic parameters, clinical features, therapies and disease characteristics with sRANKL, OPG and sRANKL/OPG ratio was further analyzed in SLE patients (Table 3). Here, TNFRSF11B is linked to systemic lupus erythematosus.